Clinical Trial Update: Efficacy and Safety of Belimumab in Primary Sjögren's Syndrome [Phase 2]

View source ↗

Summary

This document reports on the efficacy and safety outcomes from a Phase 2 trial of belimumab in primary Sjögren's syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sjögren Syndrome

Drugs mentioned

• Belimumab (belimumab)

Snippet

Sponsor: University of Udine | Conditions: Sjögren's Syndrome | Phase 2 | Status: COMPLETED